Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
The Journal of Investigative Dermatology|October 9, 2018
Dermal CD207-Negative Migratory Dendritic Cells Are Fully Competent to Prime Protective, Skin Homing Cytotoxic T-Lymphocyte ResponsesTobias Hain, Felix Melchior, Nadine Kamenjarin, et al.
Signal Transduction and Targeted Therapy|August 28, 2025
The deacetylases HDAC1/HDAC2 control JAK2V617F-STAT signaling through the ubiquitin ligase SIAH2Al-Hassan M Mustafa, Giuseppe Petrosino, Marten A Fischer, et al.
Immunity|July 21, 2023
Targeted removal of macrophage-secreted interleukin-1 receptor antagonist protects against lethal Candida albicans sepsisHang Thi Thuy Gander-Bui, Joëlle Schläfli, Johanna Baumgartner, et al.
NPJ Vaccines|September 24, 2022
Dithranol as novel co-adjuvant for non-invasive dermal vaccinationJulian Sohl, Ann-Kathrin Hartmann, Jennifer Hahlbrock, et al.
Blood|December 24, 2023
Targeting the tissue factor coagulation initiation complex prevents antiphospholipid antibody developmentNadine Müller-Calleja, Kristin Grunz, T Son Nguyen, et al.
The Journal of Clinical Investigation|July 2, 2026
Extracellular matrix reprogramming by the YAP/TAZ- TGF-ß2 axis drives immune exclusion in cholangiocarcinoma modelsMarco Jessen, KyungMok Kim, Marie Tollot-Wegner, et al.
Blood|June 3, 2026
Type I interferon-activated NK cells control polycythemia vera in vivoJohanna Lossa, Tina M Schnöder, Zora Ronge, et al.
Nature Immunology|November 7, 2018
Tumor immunoevasion via acidosis-dependent induction of regulatory tumor-associated macrophagesToszka Bohn, Steffen Rapp, Natascha Luther, et al.
Nature Immunology|January 20, 2015
Protein kinase CK2 enables regulatory T cells to suppress excessive TH2 responses in vivoAlexander Ulges, Matthias Klein, Sebastian Reuter, et al.
Blood|March 18, 2026
Inhibition of p300/CREBBP catalytic activity drives context-dependent transcriptional activation in AMLMarkus Meyerhöfer, Yawen Zhou, Aaron Gallego-Crespo, et al.
Pageof 3